Chiayi Chang Gung Memorial Hospital

Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study

Patients with esophageal squamous cell carcinoma (ESCC) have an unmet need for new therapies that improve survival. In this phase II trial, patients received ociperlimab and tislelizumab (A) or placebo and tislelizumab (B) (NCT04732494). The primary endpoint was objective respons...

Clinical Safety Awareness and Self-Efficacy in MRI Safety Practice Among Nursing Professionals: A Cross-Sectional Study

Purpose The purpose was to examine the relationships among MRI safety knowledge, clinical safety awareness, and self-efficacy in MRI safety practice among nursing professionals and to identify the factors most strongly associated with self-efficacy. Methods A cross-sectional surv...